HomeCompareCIERF vs JNJ

CIERF vs JNJ: Dividend Comparison 2026

CIERF yields 0.01% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $7.5K in total portfolio value· pulled ahead in Year 4
10 years
CIERF
CIERF
● Live price
0.01%
Share price
$3.93
Annual div
$0.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.0K
Annual income
$1,578.15
Full CIERF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CIERF vs JNJ

📍 JNJ pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIERFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIERF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIERF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIERF
Annual income on $10K today (after 15% tax)
$1.21/yr
After 10yr DRIP, annual income (after tax)
$1,341.43/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $2,695.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIERF + JNJ for your $10,000?

CIERF: 50%JNJ: 50%
100% JNJ50/50100% CIERF
Portfolio after 10yr
$26.7K
Annual income
$3,164.02/yr
Blended yield
11.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CIERF
No analyst data
Altman Z
2.6
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIERF buys
0
JNJ buys
0
No recent congressional trades found for CIERF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIERFJNJ
Forward yield0.01%2.14%
Annual dividend / share$0.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$23.0K$30.5K
Annual income after 10y$1,578.15$4,749.88
Total dividends collected$3.1K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIERF vs JNJ ($10,000, DRIP)

YearCIERF PortfolioCIERF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,703$2.84$10,594$274.49+$109.00CIERF
2$11,458$5.67$11,294$360.69+$164.00CIERF
3$12,271$11.35$12,133$476.91+$138.00CIERF
4← crossover$13,153$22.72$13,156$635.42$3.00JNJ
5$14,119$45.52$14,432$854.61$313.00JNJ
6$15,199$91.33$16,056$1,162.76$857.00JNJ
7$16,446$183.77$18,175$1,604.53$1.7KJNJ
8$17,969$371.70$21,009$2,252.68$3.0KJNJ
9$19,986$759.11$24,911$3,229.73$4.9KJNJ
10$22,963$1,578.15$30,458$4,749.88$7.5KJNJ

CIERF vs JNJ: Complete Analysis 2026

CIERFStock

CHIeru Co.,Ltd. engages in the production of ICT environments for teaching and learning in schools in Japan and internationally. The company's services include software and system products, teaching and learning resources, and strategic consulting for school ICT environments in primary and higher education. It offers InterCLASS Cloud, a cloud-based classroom management software; CaLabo EX, a computer-assisted digital language lab solution; and CaLabo LX software to support teacher and student activities in PC lab, classroom, and library/media centers. The company was founded in 2006 and is headquartered in Tokyo, Japan. CHIeru Co.,Ltd. is a joint venture of Alps System Integration Co., Ltd. and Obunsha Co., Ltd.

Full CIERF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CIERF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIERF vs SCHDCIERF vs JEPICIERF vs OCIERF vs KOCIERF vs MAINCIERF vs ABBVCIERF vs MRKCIERF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.